Share
Market Research Report

MORPHINE, BUPRENORPHINE, AND OTHER DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By DrugMorphine · Buprenorphine · Noscapin · Thebaine · Etrophine
  • By ApplicationPain Management · Opioid Addiction Treatment · Others
  • By Route Of AdministrationInjectable · Oral · Transdermal
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In25 Jun 2026
  • Report CodeCMI4637
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug
      • Market Snapshot, By Application
      • Market Snapshot, By Route Of Administration
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Product Approval
    • Collaboration/Merge/Acquisition
    • Regulatory Landscape
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Epidemiology
    • Robust Pipeline Analysis
  4. Morphine, Buprenorphine, and Other Drugs Market, By Drug, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Morphine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Buprenorphine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Noscapine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Thebaine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Etrophine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
  5. Morphine, Buprenorphine, and Other Drugs Market, By Application, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Pain Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Opioid Addiction Treatment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
  6. Morphine, Buprenorphine, and Other Drugs Market, By Route Of Administration, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Transdermal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
  7. Morphine, Buprenorphine, and Other Drugs Market, By Distribution Channel, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
  8. Morphine, Buprenorphine, and Other Drugs Market, By Region, 2021 – 2033, (USD Billion)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
    • Company Profile
      • Purdue Pharma
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Sun Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Pfizer Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • West Ward Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Teva Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Piramal Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Hikama Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Indivior PLC
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Oreoxo AB
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Camurus AB
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Novartis
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
    • Analyst Views
  10. Section

    • References
    • Research Methodology
    • About Us